At Ease: How GentleCure™ Eliminates Skin Cancer With a Breakthrough, Noninvasive, Noncutting Procedure

The dermatology practice where Brian sought treatment, like more than 400 other dermatology practices around the country, ...

Edap Tms Talks Surging HIFU Demand, Focal One i Launch and Reimbursement Tailwinds at Conference

EDAP management highlighted what it sees as a growing global opportunity for therapeutic ultrasound in urology, emphasizing the company’s Focal One robotic high-intensity focused ultrasound (HIFU) ...
Healio

Linerixibat lands FDA first for cholestatic pruritus in primary biliary cholangitis

The FDA has approved the first medication for cholestatic pruritus in adult patients with primary biliary cholangitis.The approval of linerixibat (Lynavoy, GSK) — an ileal bile acid transporter ...
MedPage Today

Non-Ablative Treatment for BPH/LUTS Achieves Rapid, Sustained Improvements

A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...
Medscape

Linerixibat (Lynavoy) for Cholestatic Pruritus Wins FDA Nod

The oral ileal bile acid transporter inhibitor significantly and rapidly reduced cholestatic pruritus in patients with PBC in the phase 3 GLISTEN trial.

Weight-loss treatment is on the verge of a dramatic shift – again

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

Scientists May Have Just Discovered a More Effective Hair Loss Treatment

You’ve got options when it comes to treating hair loss, but you’re also probably aware that there’s no magic fix. Even the most effective treatments don't work for certain people (and some of them ...
Pharmabiz

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia

Prodeon Medical’s Urocross Expander System receives US FDA 510(k) clearance for treating urinary symptoms associated with benign prostatic hyperplasia: Sunnyvale, California Thu ...
The Print

Capitol Hospital Urology Experts Advise: Don’t Ignore the Signs of Prostate Enlargement

As men age, their bodies go through many natural changes. One such change, often less spoken about, is the enlargement of the ...
MedTech Intelligence

Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia

The Urocross Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.
on3

UNC Officials Seeking Alignment as Smith Center Decision Nears

On Monday evening, University of North Carolina officials held a video conference call with former UNC basketball players to present their findings from a years-long study into the future of the Dean ...

Prodeon Medical Receives FDA 510(k) Clearance for the Urocross(R) Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with ...

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...